Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Pegaspargase · Oncaspar

Recombinant protein · Protein replacement: asparagine · developed by Sigma Tau

Approved FDA, Feb 1994
1 Registered trials

What is Pegaspargase?

Pegaspargase is a polyethylene glycol conjugated L-asparaginase enzyme that hydrolyzes the amino acid L-asparagine into aspartic acid and ammonia. Leukemic cells with low asparagine synthetase expression depend on external asparagine, so its depletion blocks protein synthesis and induces apoptosis in these cells. It is used in acute lymphoblastic leukemia.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Oncaspar, PEG asparaginase
Drug type
Recombinant protein
Targets
asparagine
Mechanism
Protein replacement: asparagine
Pathways
asparagine depletion, protein synthesis inhibition, apoptosis
Therapy area
Oncology
Developer
Sigma Tau
In trials of
KURA
FDA status
Approved as Oncaspar (February 1, 1994), BLA103411 · FDA label
UNII
7D96IR0PPM

✅ FDA-approved uses

From the indications section of the FDA label (version of Oct 7, 2024). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT05848687 Phase 1/2 Lymphoblastic Leukemia Recruiting KURA

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Lymphoblastic Leukemia

Sources

Updated Oct 18, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.